[1]
E. Lubrano and A. Spadaro, “Certolizumab: efficacy and safety profile of a novel pegylatedTNF-alpha blocking agent”, Acta Biomed, vol. 82, no. 1, pp. 26–34, Sep. 2011, Accessed: Jul. 27, 2024. [Online]. Available: https://mattioli1885journals.com/index.php/actabiomedica/article/view/1362